Received Feb 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 7P7L9 | — |
Possible administration of only the diluent/dose of Hiberix had accidentally been administered without proper reconstitution,; Possible administration of only the diluent/dose of Hiberix had accidentally been administered without proper reconstitution,; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 6-month-old female patient who received Hib (Hiberix) (batch number 7P7L9, expiry date 08-DEC-2026) for prophylaxis. Previously administered products included Hiberix (1st dose Received on unknown dose). On 30-JAN-2026, the patient received the 2nd dose of Hiberix. On 30-JAN-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Possible administration of only the diluent/dose of Hiberix had accidentally been administered without proper reconstitution,) and inappropriate dose of vaccine administered (Verbatim: Possible administration of only the diluent/dose of Hiberix had accidentally been administered without proper reconstitution,). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date:11-FEB-2026 They had been unsure which of the four patients involved had received the improper dose. They had called to request information about any GSK data regarding the administration of a third dose of Hiberix. They had been uncertain which patient had not received the correct dose. They had been planning to administer an additional dose to the patients involved. The case has been linked with case US2026020495, US2026020496, US2026020497, US2026020495 reported by Same reporter/Different patient; Sender's Comments: US-GSK-US2026020495:Same reporter/Different patient US-GSK-US2026020496:Same reporter/Different patient US-GSK-US2026020497:Same reporter/Different patient US-GSK-US2026020495:SAME REPORTER